Skip to main content
Search

The multidimensional landscape of pharmacovigilance: introduction and history

Part 1 of 2
Published on June 29, 2023   33 min

A selection of talks on Pharmaceutical Sciences

Please wait while the transcript is being prepared...
0:00
Ladies and gentlemen, my name is Ulrich Hagemann. Welcome to this talk about the multidimensional landscape of pharmacovigilance.
0:13
I got my university education in Pharmacy and Biochemistry at the Free University of Berlin. Thereafter I started to work for the German medicines National Drug Agency, the Federal Institute of drugs and medical devices, first in Berlin and later in Bonn. Since 1996, I was leading the pharmacovigilance department at this institute until my retirement in 2011. Currently, I'm retired and a member of the Editorial Board, of the International Journal of Risk and Safety in Medicine.
0:55
These are my conflicts of interests. I have no conflicts of interests to be declared. The views expressed in this presentation reflect my personal views of the issue.
1:09
I have decided to divide my talk into two parts because there are different issues which relate to pharmacovigilance, but which are not really straightforward connected. In this first part, I would like to talk about the history and disasters in pharmacovigilance, I would like to address the science and knowledge which are needed in pharmacovigilance and the areas of research. I would like to outline what is the link between pharmacovigilance and public health and what is the needed clinical medicine expertise in pharmacovigilance.
Show
Hide

The multidimensional landscape of pharmacovigilance: introduction and history

Embed in course/own notes